CYSLTR1
Basic information
Region (hg38): X:78271468-78327691
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYSLTR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 2 | 0 |
Variants in CYSLTR1
This is a list of pathogenic ClinVar variants found in the CYSLTR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-78272743-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
X-78272747-T-G | not specified | Uncertain significance (Dec 05, 2024) | ||
X-78272813-G-C | not specified | Uncertain significance (Jun 12, 2023) | ||
X-78272865-T-C | Likely benign (Apr 01, 2022) | |||
X-78272887-T-C | not specified | Uncertain significance (Dec 14, 2022) | ||
X-78272951-G-A | not specified | Uncertain significance (Oct 25, 2023) | ||
X-78272966-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
X-78272989-C-T | not specified | Uncertain significance (Apr 22, 2024) | ||
X-78273014-T-A | not specified | Uncertain significance (Jun 18, 2021) | ||
X-78273035-C-T | not specified | Uncertain significance (Nov 17, 2023) | ||
X-78273260-G-C | not specified | Uncertain significance (Apr 18, 2024) | ||
X-78273292-A-T | not specified | Uncertain significance (May 04, 2023) | ||
X-78273293-T-A | not specified | Uncertain significance (May 04, 2023) | ||
X-78273386-G-A | not specified | Conflicting classifications of pathogenicity (Jul 14, 2024) | ||
X-78273398-T-C | not specified | Uncertain significance (Jun 29, 2023) | ||
X-78273457-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
X-78273459-G-C | not specified | Uncertain significance (Mar 24, 2023) | ||
X-78273511-C-A | not specified | Uncertain significance (Apr 17, 2023) | ||
X-78273563-T-C | not specified | Uncertain significance (Dec 06, 2024) | ||
X-78273584-T-G | not specified | Uncertain significance (Sep 03, 2024) | ||
X-78273602-T-C | not specified | Uncertain significance (Jul 22, 2024) | ||
X-78273678-AT-A | Malignant tumor of prostate | Uncertain significance (-) | ||
X-78273682-C-T | not specified | Uncertain significance (Aug 04, 2024) | ||
X-78273698-T-G | not specified | Uncertain significance (Dec 08, 2023) | ||
X-78273725-T-C | not specified | Uncertain significance (Jul 31, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYSLTR1 | protein_coding | protein_coding | ENST00000373304 | 1 | 56088 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0120 | 0.660 | 125655 | 9 | 11 | 125675 | 0.0000796 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.768 | 148 | 124 | 1.19 | 0.00000898 | 2245 |
Missense in Polyphen | 43 | 49.43 | 0.86992 | 798 | ||
Synonymous | -2.66 | 67 | 44.4 | 1.51 | 0.00000311 | 653 |
Loss of Function | 0.492 | 3 | 4.07 | 0.737 | 2.52e-7 | 107 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000762 | 0.0000615 |
Ashkenazi Jewish | 0.000135 | 0.0000992 |
East Asian | 0.0000723 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000184 | 0.000132 |
Middle Eastern | 0.0000723 | 0.0000544 |
South Asian | 0.000108 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for cysteinyl leukotrienes mediating bronchoconstriction of individuals with and without asthma. Stimulation by LTD4 results in the contraction and proliferation of smooth muscle, edema, eosinophil migration and damage to the mucus layer in the lung. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. The rank order of affinities for the leukotrienes is LTD4 >> LTE4 = LTC4 >> LTB4.;
- Pathway
- Calcium signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Leukotriene modifiers pathway, Pharmacodynamics;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;eicosanoid metabolism;Eicosanoid ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;Leukotriene receptors;G alpha (q) signalling events;GPCR downstream signalling;Endothelins
(Consensus)
Recessive Scores
- pRec
- 0.158
Intolerance Scores
- loftool
- 0.657
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 37.11
Haploinsufficiency Scores
- pHI
- 0.156
- hipred
- N
- hipred_score
- 0.253
- ghis
- 0.515
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.159
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cysltr1
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; immune system phenotype; cellular phenotype;
Gene ontology
- Biological process
- inflammatory response to antigenic stimulus;calcium ion transport;chemotaxis;defense response;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;neuropeptide signaling pathway;respiratory gaseous exchange;leukotriene signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane;membrane
- Molecular function
- galanin receptor activity;leukotriene receptor activity;protein binding;G protein-coupled peptide receptor activity